To

The Members

The Directors are pleased to present their report on the business and operations of your Company along with the Audited Financial Statements for the Financial Year ("FY") ended 31 st March, 2026.

1. FINANCIAL HIGHLIGHTS

(` in million)

2. (A) FINANCIALS

During FY 2025-26, on standalone basis revenue from operations were ` 8,153.35 million as against ` 9,223.16 million in 2024-25. The Profit Before Tax was ` 3,356.11 million as against ` 3905.50 million in 2024-25. The Profit after tax was ` 2,512.17 million as against ` 2,923.02 million in 2024-25.

During 2025-26, on consolidated basis revenue from operations were ` 9,565.47 million. The Profit Before Tax was ` 3,096.70 million and the Profit after tax was ` 2,296.55 million.

(B) BUSINESS OUTLOOK

Outlook of the Business has been discussed in the Management Discussion and Analysis which forms part of this Annual Report.

(C) HIGHLIGHTS OF PERFORMANCE OF SUBSIDIARY/ASSOCIATE/JOINTVENTURE COMPANIES

The Shareholders are requested to refer

Annexure II (Form-AOC-1) to get the highlights of performance of subsidiaries and their contribution to the overall performance of the Company during the year under review.

3. DIVIDEND

The Board of Directors, at its meeting held on 31 st January, 2026, declared an interim dividend of ` 2/- (200%) per equity share of ` 1/- each for FY 2025-26. The said interim dividend was paid to those members whose names appeared in the Register of Members as on 6 th February, 2026, being the record date fixed for the purpose. The total cash outflow on account of the interim dividend amounted to ` 212.55 Million.

Further, the Board of Directors, at its meeting held on 14 th May, 2026, has recommended a final dividend of ` 4/- (400%) per equity share of ` 1/- each for FY 2025-26, subject to the approval of the members at the ensuing Annual General Meeting ("AGM").

The final dividend, if approved, shall be paid after deduction of tax at source, as applicable.

The Company has complied with its Dividend Distribution Policy in respect of the declaration and payment/recommendation of dividend during the year under review.

Your Company is in compliance with the Company's Dividend Distribution Policy.

The Dividend Distribution Policy in accordance with Regulation 43A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations 2015") is attached to this report as Annexure I and is also available on the Company's website on web link https://cleanscience.co.in/wp-content/uploads/2023/02/Dividend-Distribution-Policy.pdf

4. CAPITAL STRUCTURE

The Authorised Share Capital of the Company as at 31 st March, 2026 stood at ` 150 million comprising 150,000,000 Equity Shares of ` 1/- each.

During the year under review, the Company allotted 10,040 Equity Shares of ` 1/- each to eligible employees pursuant to the Clean Science and Technology Limited Employee Stock Option Scheme, 2021. Consequently, the Issued, Subscribed and Paid-up Equity Share Capital of the Company increased from ` 106.27 million comprising 10,62,67,259 Equity Shares of ` 1/- each to ` 106.28 million comprising 10,62,77,299 Equity Shares of ` 1/- each.

Further, pursuant to Regulation 29 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, members of the Promoter and

Promoter Group, during August 2025, of floaded 2,55,00,480 Equity Shares aggregating to 24% of the paid-up equity share capital of the Company through the open market mechanism. The requisite compliances and disclosures in this regard were duly complied with.

Further, during November 2025, pursuant to Regulation 29 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, an inter-se transfer of 1,78,49,476 Equity Shares was undertaken amongst the members of the Promoter and Promoter Group of the Company. All applicable disclosures and compliances under the SEBI Regulations and the Companies Act, 2013 were duly complied with from time to time.

During the year under review, the Company did not undertake any rights issue, bonus issue, preferential allotment or any other form of capital issuance. Further, the Company has not issued any shares with differential voting rights or sweat equity shares.

5. EMPLOYEE STOCK OPTION SCHEME 2021

The Company recognises that its employees are integral to its sustained growth and success and regards them as one of its key stakeholders. In order to recognise and reward employees for their performance and to encourage their continued contribution towards the growth and profitability of the Company, the Company has implemented the Clean Science and Technology Limited Employee Stock Option Scheme 2021 (CSTL ESOS 2021).

Pursuant to Regulation 14 read with Part F of Schedule I of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the details of the CSTL ESOS 2021 are provided in Annexure VII forming part of this Report.

A certificate from the Secretarial Auditors confirming that the Scheme has been implemented in accordance with the applicable provisions of the SEBI Regulations will be placed before the ensuing Annual General Meeting and shall be available for inspection by the Members. The certificate will also be available for inspection at the Registered Office of the Company.

6. SUBSIDIARY, ASSOCIATES OR JOINT VENTURES

The Company has 4 (Four) wholly owned subsidiaries at the end of FY namely Clean Fino-Chem Limited, Clean Science Private Limited, Clean Organics Private Limited and Clean Aromatics Private Limited.

Investment in Clean Fino-Chem Limited

During the year, the Company made additional equity investment of ` 2030 million in Clean Fino-Chem Limited (CFCL) to fund its capex plans.

Changes in Management of CFCL:

Mr. Pradeep Mehendale was appointed as an Additional Director – factory occupier of the CFCL on 16 th July, 2025 Mr. Parth Maheshwari, resigned as Director of the Company to pursue his personal interest with effect from 1 st January, 2026.

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Secretarial Audit Report of Clean Fino-Chem Limited forms part of this Annual Report as Annexure X.

7. RESERVES

The Directors do not propose to transfer any amount to the Free Reserves.

8. DEPOSITS

During the year under review, your Company has not accepted any deposits from the public pursuant to Section 73 and Section 76 of the Companies Act, 2013 read with The Companies (Acceptance of Deposits) Rules 2014.

9. DIRECTORS' RESPONSIBILITY STATEMENT

Pursuant to Section 134(5) of the Companies Act, 2013, the Directors of the Company, to the best of their knowledge and belief state that: i) in the preparation of the annual accounts for the FY ended 31 st March, 2026, the applicable accounting standards have been followed with proper explanation relating to material departures; ii) they have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at 31 st March, 2026 and of the profit and loss of the Company for the year ended on that date;

iii) they have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; iv) they have prepared the annual accounts on a going concern basis; v) they have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively for the FY ended 31 st March 2026;

vi) the Directors, had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and operating effectively for the FY ended 31 st March 2026.

10. CORPORATE GOVERNANCE

Pursuant to the SEBI Listing Regulations, 2015, a separate section titled 'Report on Corporate Governance' and Shareholders' Information has been included in this Annual Report.

A Certificate from Secretarial Auditor of the Company regarding compliance with the conditions of Corporate Governance as stipulated under Schedule V of SEBI Listing Regulation 2015 is annexed to the Report on Corporate Governance.

11. MANAGEMENT DISCUSSION AND ANALYSIS

A Management Discussion and Analysis Report containing details relating to Industry Trends, Company Performance, Business and Operations forms part of this Annual Report.

12. BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT

In terms of Regulation 34(2) of the SEBI Listing Regulations, 2015, a Business Responsibility and Sustainability Report (BRSR) for the FY 2025-26 forms part of this Annual Report.

13. INSURANCE

The properties, insurable assets of the Company such as buildings, plants, machineries and stocks among others are adequately insured.

14. CHANGE IN THE NATURE OF BUSINESS, IF ANY

During the year under review, there was no change in the nature of Company's business.

15. MATERIAL CHANGES AND COMMITMENTS, IF ANY, AFFECTING THE FINANCIAL POSITION OF THE COMPANY

Apart from additional equity investment of ` 500 million in Clean Fino-Chem Limited on 8 th April 2026, there were no material changes and commitments, occurred from the end of the FY till the date of this report, which may materially affect the financial position of the Company.

16. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO

The information on conservation of energy, technology absorption and other details stipulated under Section 134(3)(m) of the Companies Act, 2013 read with Rule 8 of The Companies (Accounts) Rules, 2014, is attached to this report as Annexure III .

17. SAFETY, HEALTH AND ENVIRONMENT

Your Company has in place Responsible Care Policy and is committed to excellence and continued improvements in Environment, Health, Safety and Security (EHSS) performance at all manufacturing units.

Safety

The Company encourages a high level of Safety, awareness amongst the employees and strive for continual improvement. Employees are trained in safe practices to be followed at the workplace. Following steps were taken by the Company for Safe work environment:

• As a new initiative Behaviour Based Safety (BBS) training had been imparted to almost all employees at the manufacturing locations.

• The manufacturing units were equipped with self-contained breathing apparatus (SCBA), gas leak detectors, foam and water sprinkler system and other protective devices.

• Review meetings conducted monthly by the safety department for the root-cause-analysis (RCA) of incidents occurred and to design corrective-and-preventive-actions (CAPA).

• Hazardous chemicals like Phenol, DCC were handled in closed loop and wearing PPE's like pressure suit, hand gloves.

• Strict compliance with all legal and statutory requirement. PESO guidelines is followed for flammable solvents, Gas cylinder rule for handling and storage of gas cylinders and NDPS Act (Acetic anhydride) etc.

Certifications awarded such as ISO 9001, ISO

14001, ISO45001, US FDA (Bioterrorism), FSSC 22000 EU Reach, Responsible Care.

• The Company follow OSHA PSM element to maintain EHS system.

• Risk assessment carried out for all activities by various techniques like PSI, HAZOP, HIRA, QRA, PSSR, LOPA, JSA and Engineering controls are implemented to mitigate risk

• Protective gears provided to all employees for safe material handling. Plant level training and development programmes are organised regularly.

• Training and awareness session are organised by in-house as well as from external expertise.

• Promotional activities are carried out at site like National Safety Week, Road Safety Week, Fire service week, World Environment day.

• Annual Day Celebration includes safety plays, skits to create awareness amongst employees.

During the year Company conducted 18,112 hours of training in following departments: -

a) Safety & Environment: 1,304 b) Production: 11,874 c) Engineers and Project Engineers: 3,456

d) QC R&D: 819 e) Admin, Purchase, Store, IT: 658

Health

The health and well-being of employees remains a foremost priority for the Company. All new employees at the manufacturing facilities undergo pre-employment medical examinations and induction training programmes. In addition, periodic health check-ups of employees are conducted by qualified medical professionals.

The Company regularly monitors work areas to assess chemical concentration levels, noise levels and ambient air quality in accordance with the National Ambient Air Quality Standards. The manufacturing units are equipped with Occupational Health Centres staffed with qualified doctors and nursing personnel, along with ambulance facilities to provide immediate medical assistance to employees. The Company has also entered into arrangements with nearby hospitals for specialised medical support, whenever required. Further, the Company has trained employees in first-aid practices to provide emergency medical assistance during duty hours. Employees are also covered under adequate health and accident insurance policies.

Environment

Environmental protection remains one of the highest priorities of the Company. The Company is committed to conducting its operations in an environmentally responsible and sustainable manner and ensures that its facilities are equipped with adequate effluent treatment systems to minimise environmental contamination and pollution.

The Company actively promotes and encourages the "3R" principles — Reduce, Recycle and Reuse — across all levels of the organisation as part of its sustainability initiatives.

Detailed disclosures relating to environmental protection and sustainability initiatives are provided in the Business Responsibility and Sustainability Report, forming part of the Board's Report as an Annexure thereto.

Significant Achievements in Sustainability:

The Company remains committed to minimising the environmental impact of its operations by reducing the discharge of wastewater, emissions and hazardous substances into the environment. During the year under review, the Company implemented various sustainability initiatives aimed at improving environmental performance and promoting sustainable operations.

Reduction in Fresh Water Consumption:

The Company has established a robust rainwater harvesting system for collection, filtration and recycling of rainwater for internal consumption. Further, the Company continues to undertake initiatives to optimise process heat utilisation, thereby minimising water evaporation losses and reducing overall water consumption.

Responsible Care Certification:

The Company has received Responsible Care

Certification from the Indian Chemical Council for a period of three years, (2025-2027) reaffirming its commitment towards sustainable and responsible chemical manufacturing practices.

Tree Plantation Initiative:

As part of its Corporate Social Responsibility ("CSR") initiatives, the Company planted more than 18,000 trees over an area admeasuring approximately 10 hectares situated at Village Girim, Taluka Daund, District Pune, on land belonging to the Forest Department

18. CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES

All transactions entered into with related parties during the financial year were in ordinary course of business and at arm's length basis, which were approved by the Audit Committee. In compliance with Regulation 23(2) of the SEBI Listing Regulations, 2015, the Audit Committee of the Company approved the Related Party Transaction entered into by the Subsidiary Company(ies).

The Board has approved a policy for related party transactions which is available on the Company's website at https://cleanscience.co.in/wp-content/ uploads/2025/04/Policy-on-Related-Par ty-Transactions-Amended-30012025.pdf The particulars of contracts or arrangements made with related parties is covered in Notes to the Financial Statements. There are no material contracts / arrangements made with related parties as required under Section 134(3)(h) of the Companies Act, 2013 as given in Form AOC-2 which is attached as Annexure IV to this report. None of the transactions with any of the related parties were in conflict with the interest of the Company.

The particulars of loans/advances/investments etc., required to be disclosed pursuant to Para A of Schedule V of the SEBI Listing Regulations, 2015, are furnished as a part of the Financial Statements. The transaction(s) of the Company with any person or entity belonging to the promoter / promoter group which hold(s) more than 10% shareholding in the Company as required pursuant to Para A of Schedule V of the SEBI Listing Regulations, 2015 is disclosed separately in the Financial Statements of the Company.

19. BOARD AND ITS COMMITTEES

During the FY 2025-26, 4 (Four) Board Meetings were held. For the details of composition and meetings of the Board and its Committees, please refer the Corporate Governance Report forming part of this annual report.

The committees of Board has been reconstituted on 31 st January, 2026 consequent to changes in Board members.

20. CORPORATE SOCIAL RESPONSIBILITY

The Corporate Social Responsibility ("CSR") activities of the Company are governed by the Corporate Social Responsibility Policy approved by the Board of

Directors. The Company firmly believes that CSR and sustainability are intrinsically linked and endeavors to contribute meaningfully towards building a better and more sustainable future. Through its CSR initiatives, the Company continuously strives to support the social and economic development of the communities in which it operates.

The Company recognises its social responsibility and remains committed to creating long-term value for society by undertaking initiatives aimed at sustainable development and community welfare for future generations.

During the year under review, the Company spent `76.44 million towards CSR activities. The Company undertook CSR initiatives in the following areas: a) Promoting Education; b) Promoting Healthcare including Preventive Healthcare; c) Ensuring environmental sustainability; d) Livelihood enhancement Projects; e) promotion and development of traditional arts and handicrafts; f) Promotions of Sports Activities; g) Skill Development; h) Eradicating hunger, poverty and Malnutrition. In terms of Section 135 read with Schedule VII of the Companies Act, 2013, and Rules made thereunder the details of CSR activities undertaken by the Company are attached to this report as Annexure V . The CSR

Policy of the Company is in terms of Companies (Corporate Social Responsibility) Rules, 2014 and is available on the Company's website at https:// cleanscience.co.in/wp-content/uploads/2023/02/ Corporate-Social-Responsibility-Policy.pdf

21. NOMINATION AND REMUNERATION POLICY

Your Company has framed a Nomination and Remuneration Policy to formulate the criteria for determining qualifications, competencies, positive attributes and independence for appointment of a director (executive/ nonexecutive/ independent), Senior Management and other employees. The Nomination and Remuneration Policy is placed on the website of the Company https://cleanscience. co.in/wp-content/uploads/2024/06/NRC_Policy_ updated_06_2024.pdf

22. RISK MANAGEMENT AND INTERNAL FINANCIAL CONTROLS

Risk Management

The Company has established a comprehensive Risk Management framework and policy, which adopts an integrated approach to safeguard the organisation against strategic, operational, financial, legal and compliance risks through timely identification and appropriate mitigation measures. The framework operates across various levels of the enterprise and is designed to identify potential risks, assess their impact and implement suitable mitigation strategies to address such risks effectively.

The Company maintains a Risk Register based on probability and impact analysis. Identified risks are categorised as high, medium or low based on their potential impact on the organisation. These risks are periodically reviewed through detailed discussions with the Senior Leadership Team, Management and the Risk Management Committee. The Risk Register is placed before the Risk Management Committee at regular intervals, along with updates on actions taken for risk mitigation and control.

In accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Risk Management Committee has been constituted. The Committee is responsible for formulating a detailed risk management policy, identifying, monitoring and mitigating risks, overseeing the implementation of the risk management framework, and reviewing the adequacy of risk management and internal control systems. The Committee also ensures that appropriate methodologies, processes and systems are in place, reviews risks in light of evolving industry dynamics and ensures that the Board is kept informed of its discussions, recommendations and actions on a regular basis.

The Risk Management Committee is chaired by a Non-Executive Director, and the Chairman of the Audit Committee is also a member of the Committee. The Chairman of the Committee briefs the Board of

Directors on the significant matters discussed and decisions taken at the Risk Management Committee meetings.

The Risk Management Policy of the Company is available on the Company's website at https:// cleanscience.co.in/wp-content/uploads/2023/02/ Risk-Management-Policy.pdf

Internal Financial Controls

The Company has in place adequate internal financial controls over financial reporting. It has laid down certain guidelines, policies, processes and structures which are commensurate with the nature, size, complexity of operations and business processes followed by the Company.

The Audit Committee deliberates with the members of the Management, considers the systems as laid down and met the internal auditors and statutory auditors to ascertain their views on the internal financial control systems. The Audit Committee satisfies itself as to the adequacy and effectiveness of the internal financial control systems.

Internal financial controls and their adequacy are included in the Management Discussion and Analysis, forming part of this report.

23. SIGNIFICANT AND MATERIAL ORDERS PASSED

BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANY'S OPERATIONS IN FUTURE

No significant material orders were passed by the

Regulators/ Court which would impact the going concern status of the Company and its future operations.

24. AUDITORS AND AUDITORS REPORT a) Statutory Auditors and Audit Report

Pursuant to the provisions of Section 139 of the Companies Act, 2013, and rules made thereunder, M/s. Price Waterhouse Chartered Accountants LLP (Firm Registration No. 012754N/ N500016) were appointed as the Statutory Auditors of the Company for a period of 5 (five) years as approved at the 21 st Annual General Meeting (AGM) held on 5 th September, 2024 and will complete their 5 years tenure on the conclusion of the 26 th Annual General Meeting.

With reference to the comments made by the auditors in paragraph 15(b) of the "Other Legal and Regulatory Requirements" section of the audit report, the Board submits that, in respect certain books of accounts, the Company had implemented software configured to take daily backups. However, software did not maintain evidences/logs of such backups. Further, necessary modifications have since been implemented, and backup evidences/logs are available from 7 th May, 2025 onwards.

With respects to auditors' comments on point 15 (h)(vi) maintenance of audit log at database level in accounting software, the Board submits that enabling audit logs at the database level requires significant server storage capacity, which adversely impacts system performance and normal business operations. Further, the non-availability of pre-modified values in the accounting software and audit logs in Excel (mentioned as certain software) are due subject to the inherent technical limitations of such software.

The Companies (Amendment) Act, 2017, has amended Section 139(1) of the Companies Act, 2013, effective from 7 th May, 2018, whereby first proviso to Section 139(1) has been omitted which provided for ratification of appointment of Auditors by members at every Annual General Meeting. Accordingly, no resolution is being proposed for ratification of appointment of Statutory Auditors at the ensuing Annual General Meeting. Pursuant to Section 139 of the Companies Act, 2013 and Rules made thereunder, the Statutory Auditors have confirmed they are eligible to continue as Auditors. The notes to the Audited Financial Statements referred to in the Auditor's Report are self-explanatory and hence do not call for any further comments.

The statutory auditor's report does not contain any qualifications, reservations, or adverse remarks or disclaimer and the Auditor's Report is unmodified.

b) Secretarial Auditor

Pursuant to the provisions of Section 204 of the Companies Act, 2013, The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and SEBI Listing Regulations, 2015, as amended, as recommended by Board , Shareholders of the Company on 22 nd Annual General Meeting held on 11 th September, 2025 have appointed M/s J.

B. Bhave & Co., Practising Company Secretary, Pune (Certificate of Practice Number 3068) to undertake the Secretarial Audit of the Company for period of 5 years i.e. upto Financial Year ended 31 st March, 2030.

The Secretarial Audit Report for FY 31 st March, 2026 is annexed herewith and forms part of this report as Annexure VI.

The report does not contain any qualification, reservation or adverse remark.

c) Cost Auditors

In terms of Section 148 of the Companies Act, 2013 read with the Companies (Cost Record and Audit) Rules, 2014, the Company to maintain cost accounting records and have them audited every year.

The Board has on the recommendation of the Audit Committee re-appointed M/s Dhananjay

V. Joshi & Associates, Cost Accountants, (Firm

Registration No. 000030) as the Cost Auditors of the Company for conducting the cost audit for the FY 2025-26 and they have been reappointed as Cost Auditors of the Company for the FY 2026-27.

The remuneration payable to the Cost Auditors is required to be placed before the members

. in a General Meeting for their ratification

Accordingly, resolution seeking members ratification for the remuneration payable to M/s Dhananjay V. Joshi & Associates as a Cost Auditors for FY 2026-27 is included in the Notice convening Annual General Meeting.

M/s Dhananjay V. Joshi & Associates had confirmed that, their appointment is within the limits of Section 141(3)(g) of the Companies Act, 2013 and Rules made thereunder and had certified that they are free from any disqualifications specified under Section 141(3) and other applicable provisions of the Companies Act, 2013.

Further, the Board hereby confirms that, the maintenance of cost records specified by the Central Government as per Section 148(1) of the Companies Act, 2013 and rules made thereunder has been made and maintained.

d) Internal Auditors

In accordance with the provisions of Section 138 of the Companies Act, 2013, M/s. CNK

JBMS & Associates, Chartered Accountants, conducted Internal Audit of the Company for the FY 2025-26. Further, pursuant to the recommendation of Audit Committee, the Board of Directors at their meeting held on 14 th May, 2026 had re-appointed M/s CNK JBMS & Associates, Chartered Accountants, as the Internal Auditor of the Company to conduct Internal Audit for FY 2026-27.

25. REPORTING OF FRAUDS BY AUDITORS

During the year under review, there were no instances of fraud, which required the Statutory Auditors, Cost Auditors and Secretarial Auditors to report to the Audit Committee and / or Board under Section 143(12) of Act and Rules framed thereunder.

26. PARTICULARS OF LOANS, GUARANTEES, INVESTMENTS AND SECURITIES

During the year under review, the Company has made investments, the details of which are given under Note No. 7 and 11 of the Notes to Standalone Financial Statements of the Company for the year ended 31 st March 2026.

27. DIRECTORS AND KEY MANAGERIAL PERSONNEL

In terms of Section 152(6) of the Companies Act, 2013 and the Articles of Association of the Company Mr. Krishnakumar Ramnarayan Boob (DIN-00410672) Whole Time Director of the Company is liable to retire by rotation in the ensuing Annual General Meeting and being eligible offer himself for re-appointment.

During the year, the Shareholders approved the appointment of Mr. Raj Kamal (DIN- 01083088) and Ms. Pallavi Pratap Gokhale (DIN-00036369) as an Independent Directors with effect from 6thNovember, 2025 through postal ballot which was concluded on 16 th December, 2025.

Mr. Parth Ashok Maheshwari has tendered his resignation from the post of Whole Time Director with effect from 31 st December, 2025.

Prof. Ganapati Dadasaheb Yadav, has completed his term as a Non-Executive - Independent Director and consequently, ceased to be a Non-Executive - Independent Director with effect from 5 th February, 2026.

Ms. Madhu Dubhashi, has completed her term as a Non-Executive - Independent Director and consequently, ceased to be a Non-Executive - Independent Director with effect from 19 th February, 2026.

28. ANNUAL EVALUATION OF BOARD OF DIRECTORS, ITS COMMITTEES AND INDIVIDUAL DIRECTORS

A formal evaluation of performance of the Board, its Committees and the Individual Directors was carried out for FY 2025-26. The evaluation was carried out using individual questionnaires covering, amongst others, contribution to areas impacting company's performance, participation in Board and Committee meetings. In addition to the above, the Executive Directors were evaluated based on annual targets, financial and operational controls, risk management, strategies, expansion, maintaining corporate culture, integrity and ethics, succession planning, core governance and compliance management.

The performance of the respective Committees was evaluated by the Board after seeking inputs from the Committee members on the basis of criteria such as composition of committee, timely inputs, open communications, meaningful participation and resolution of issues.

The performance of the Board was evaluated after seeking inputs from the members on proper mix of competencies of the Board, timeliness and adequacy of information availability to take decisions, plan of actions, reporting systems, governance practices, potential conflict of interest etc.

The Board and the Nomination and Remuneration Committee reviewed the performance of the individual Directors including Independent Directors, on the basis of criteria such as contribution of the individual Director to the Board and Committee meetings and preparedness on the issues to be discussed, meaningful and constructive contribution and inputs in meetings, etc. In addition, the Chairman was also evaluated on the key aspects of his role. The Board is of the opinion that during the year all Directors including the Independent Directors of the Company possess requisite qualifications, integrity, expertise and experience (including proficiency) in their respective fields.

29. FAMILIARISATION PROGRAMME FOR INDEPENDENT DIRECTORS

The members of the Board are familiarised with the activities of the Company. The Directors are provided with documents to enable them to have better understanding of the Company, its various operations and the industry in which it operates.

Independent Directors are made aware of their roles and responsibilities at the time of appointment through formal letter of appointment. Directors interact with the management, senior leadership team of the Company which enables them to understand the Company's strategy, business updates and its model, group structure, operations, update on research and development, product offerings, markets, organisation structure, finance, human resources, technology, quality, facilities, risk management strategy, regulatory updates and governance policies. Factory visit are organised for the Directors to enable them to familiarise them with the manufacturing facilities and the processes.

The details of familiarisation programme imparted to the Independent Directors are placed on website of the Company and web link thereto is https:// cleanscience.co.in/wp-content/uploads/2026/04/ Familiarisation-programme-FY-25-26.pdf

30. DECLARATION BY INDEPENDENT DIRECTORS

Pursuant to the provisions of Section 149 of the Companies Act, 2013, the Independent Directors have submitted declarations that they meet the criteria of independence as provided under Section 149(6) of the Companies Act, 2013 along with Rules framed thereunder and Regulation 16(1)(b) of the SEBI Listing Regulations, 2015. There was no change in the circumstances affecting their status of Independent Directors of the Company.

The Board of Directors is of the opinion that the Independent Directors of the Company holds highest standards of integrity and possess requisite expertise and experience required to their duties as Independent Directors. The Independent Directors have confirmed that, they have registered themselves with Independent Directors database of The Indian Institute of Corporate Affairs (IICA) and have cleared online proficiency test as applicable.

31. VIGIL MECHANISM / WHISTLE BLOWER POLICY

The Company has adopted a Vigil Mechanism as a part of Whistle Blower Policy required under Section 177(9) of the Companies Act, 2013 and the SEBI Listing Regulations, 2015. The policy provides a mechanism for its Directors, Employees and other stakeholders of the Company to report concerns about unethical behaviour, actual or suspected fraud, actual violation of Company's Code of Conduct. It also provides for adequate safeguards against victimisation of persons who avails this mechanism and allows direct access to the Chairman of Audit Committee in exceptional cases. A quarterly report on the whistle blower complaints received is placed before the Audit Committee for its review. The said policy has been posted on website of the Company and web link thereto https://cleanscience.co.in/wp-content/uploads/2023/02/Whistle-Blower-Policy. pdf

32. ANNUAL RETURN

Pursuant to Section 92(3) read with Section 134(3) (a) of the Act, the Annual Return as on 31 st March, 2026 is available on the Company's website https://cleanscience.co.in/investors/compliance/ corporate-governance/annual-returns/

33. EMPLOYEES

The information required under section 197(12) of the Companies Act, 2013 read with Rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules 2014 is provided in Annexure VIII and IX of the Board's Report.

34. DISCLOSURE UNDER SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013

Your Company has in place a policy on Prevention of Sexual Harassment at workplace. This policy is in line with the requirements of The Sexual Harassment of Women at the Workplace (Prevention, Prohibition and Redressal) Act, 2013. All employees, whether permanent, contractual, temporary and trainees are covered under this Policy.

The Company has duly constituted internal complaint committee as required under the provisions Sexual Harassment of Woman at Workplace (Prevention, Prohibition and Redressal) Act, 2013. During the year under review, no complaints were received by the Committee. The Company is committed to provide safe and conducive work environment to all its employees and associates.

To ensure all the employees are sensitised regarding issues of sexual harassment, the Company conducts regular training and awareness programmes for its employees.

35. HUMAN RESOURCES AND INDUSTRIAL RELATIONS

The Company firmly believes that its employees are the key drivers of sustainable growth and the development of competitive advantage. The Human Resources policies and practices of the Company are focused on nurturing talent and building strong human capital.

The Company places equal emphasis on not only right hiring but also effective onboarding of new employees. Fresh talent is recruited through campus placements from both local institutions and premier educational institutes. New employees are provided with structured induction programmes to help them adapt to the work environment and are supported through training across technical, functional, leadership development and culture-building domains.

With a focus on developing internal leadership, the Company has instituted High Potential programmes to identify and groom talent for future leadership roles. The Company also provides accelerated career progression opportunities for high-potential employees across various functions. In addition, employees are encouraged to enhance their skills through internal job rotations and cross-functional exposure.

As an equal opportunity employer, the Company is committed to fostering diversity and inclusion. Women employees are provided with an enabling environment for professional growth, and the Company actively promotes women in leadership positions across the organisation.

Employee well-being and engagement remain a priority. The Company undertakes various employee welfare initiatives, including annual health checkups, celebration of festivals and employee birthdays, annual cultural programmes, sports activities such

Details are as below: as cricket tournaments, and observance of occasions such as Dussehra, Christmas and Women's Day. The Company also recognises employee contributions through felicitation of children of employees who achieve academic excellence, awards for whistle-blower employees, and special gifts on the occasion of employees' marriages.

The Company maintains transparent processes for performance management, recognition and talent retention. As on 31 st March 2026, the Company had 395 employees. Employee relations across all locations remained cordial throughout the year. The Board of Directors places on record its sincere appreciation for the dedicated efforts and contribution of all employees of the Company.

36. APPLICATION MADE OR ANY PROCEEDING PENDING UNDER INSOLVENCY AND BANKRUPTCY CODE

During the year under review, no application was made or any proceeding was pending under Insolvency and Bankruptcy code.

37. DETAILS OF DIFFERENCE BETWEEN AMOUNT OF VALUATIONS

During the year under review, no one-time settlement was done accordingly the question of difference between amount of valuation done at the time of one-time settlement and valuation done while taking loans from Banks or financial Institutions did not arise.

38. COMPLIANCE WITH SECRETARIAL STANDARDS

During the year under review, the Company has complied with applicable Secretarial Standards.

39. TRANSFER OF AMOUNTS TO INVESTOR EDUCATION AND PROTECTION FUND

The Company was not required to transfer any amounts to Investor Education and Protection Fund (IEPF).

40. ACKNOWLEDGEMENTS

Your Directors wish to place on record their profound appreciation and gratitude to the Central and State Governments, regulatory authorities, and various statutory and administrative bodies for their continued support, guidance, and cooperation extended to the Company.

The Board also conveys its sincere appreciation to the management team and employees across all levels of the organisation for their unwavering commitment, dedication, and exemplary efforts. Their professionalism, resilience, and collective contribution have been instrumental in driving the Company's performance and enabling it to achieve its strategic objectives during the year.

Your Directors further express their heartfelt gratitude to the Company's bankers, financial institutions, lenders, customers, suppliers, shareholders, advisors, rating agencies, stock exchanges, and other stakeholders for their continued trust, confidence, and support. The Board deeply values the strong relationships built over the years and looks forward to their continued partnership in the Company's journey towards sustainable growth and value creation.